AngioDynamics

What is AngioDynamics?

AngioDynamics is a company within the Healthcare category. AngioDynamics is a leading provider of innovative medical devices used by interventional radiologists, interventional cardiologists, surgeons, and other physicians for the minimally invasive diagnosis and treatment of cancer and peripheral vascular disease. Their portfolio includes products for vascular access, peripheral vascular intervention, and oncology/surgery.

When was AngioDynamics founded and where is it based?

AngioDynamics was founded in 1988 and is headquartered in Latham, New York, USA.

What problems does AngioDynamics solve for buyers?

Buyers turn to AngioDynamics for Traditional open surgery: For conditions like peripheral artery disease or certain cancers, alternatives might involve more invasive surgical procedures instead of AngioDynamics' minimally invasive de, Specialized contract research organization (CRO): Instead of using in-house clinical data or directly engaging with AngioDynamics, healthcare providers might rely on independent CROs for research and , Symptomatic management without intervention: In some cases, patients might opt for palliative care or symptomatic management without device-based intervention, depending on the condition and patient p, among 3 documented problem areas.

What questions do buyers ask AI about AngioDynamics?

Buyers evaluating AngioDynamics typically ask AI models about "AngioDynamics medical devices", "NanoKnife cancer treatment", "AngioDynamics stock", and 3 similar queries.

What does AngioDynamics offer?

AngioDynamics's core products are Vascular access (e.g., PICCs, Midlines), Peripheral Vascular Intervention (e.g., Auryon atherectomy, mechanical thrombectomy), Oncology/Surgery (e.g., NanoKnife, microwave ablation)..

How is AngioDynamics priced?

AngioDynamics uses B2B sales, capital equipment sales, disposable product sales, service contracts..

Who does AngioDynamics target?

AngioDynamics serves Hospitals, outpatient clinics, interventional radiology, interventional cardiology, surgical oncology, vascular surgery..

What differentiates AngioDynamics from competitors?

AngioDynamics Portfolio of innovative, minimally invasive devices addressing significant clinical needs in oncology and vascular health, including unique technologies like NanoKnife's IRE.

Problems this brand solves

• Traditional open surgery: For conditions like peripheral artery disease or certain cancers, alternatives might involve more invasive surgical procedures instead of AngioDynamics' minimally invasive de
• Specialized contract research organization (CRO): Instead of using in-house clinical data or directly engaging with AngioDynamics, healthcare providers might rely on independent CROs for research and
• Symptomatic management without intervention: In some cases, patients might opt for palliative care or symptomatic management without device-based intervention, depending on the condition and patient p

Buyers search for

• AngioDynamics medical devices
• NanoKnife cancer treatment
• AngioDynamics stock
• Auryon atherectomy system
• AngioDynamics direct competitors
• Alternative imaging modalities: For diagnosis or guidance, alternative imaging systems or less specialized devices from other manufacturers could be used.

About this profile

This Business Profile is published by Optimly in the Optimly AI Brand Index, a public research dataset showing how AI systems describe brands, categories, and competitors. Optimly AI Visibility analyzes sampled buyer-intent responses, cited sources, and public brand information. The Brand Authority Index summarizes answer presence, narrative accuracy, and owned citations where sufficient evidence is available.

If this is your brand, you can claim this profile to verify its contents and correct what AI models say about you: Claim this profile